Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5198091
Max Phase: Preclinical
Molecular Formula: C34H44N6O5S
Molecular Weight: 648.83
Associated Items:
ID: ALA5198091
Max Phase: Preclinical
Molecular Formula: C34H44N6O5S
Molecular Weight: 648.83
Associated Items:
Canonical SMILES: COCc1ccc(-c2cccc(S(=O)(=O)N[C@@H](Cc3cccc(C(=N)N)c3)C(=O)N3CCC(NC(=O)NC(C)(C)C)CC3)c2)cc1
Standard InChI: InChI=1S/C34H44N6O5S/c1-34(2,3)38-33(42)37-28-15-17-40(18-16-28)32(41)30(20-24-7-5-9-27(19-24)31(35)36)39-46(43,44)29-10-6-8-26(21-29)25-13-11-23(12-14-25)22-45-4/h5-14,19,21,28,30,39H,15-18,20,22H2,1-4H3,(H3,35,36)(H2,37,38,42)/t30-/m0/s1
Standard InChI Key: RZAUWGVJQTZWAS-PMERELPUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 648.83 | Molecular Weight (Monoisotopic): 648.3094 | AlogP: 3.76 | #Rotatable Bonds: 11 |
Polar Surface Area: 166.71 | Molecular Species: BASE | HBA: 6 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 10.04 | CX Basic pKa: 11.47 | CX LogP: 2.19 | CX LogD: 0.27 |
Aromatic Rings: 3 | Heavy Atoms: 46 | QED Weighted: 0.16 | Np Likeness Score: -1.14 |
1. Pilgram O, Keils A, Benary GE, Müller J, Merkl S, Ngaha S, Huber S, Chevillard F, Harbig A, Magdolen V, Heine A, Böttcher-Friebertshäuser E, Steinmetzer T.. (2022) Improving the selectivity of 3-amidinophenylalanine-derived matriptase inhibitors., 238 [PMID:35635944] [10.1016/j.ejmech.2022.114437] |
Source(1):